STRUCTURE ACTIVITY RELATIONSHIP STUDY OF HUMAN INTERLEUKIN-3 - ROLE OF THE C-TERMINAL REGION FOR BIOLOGICAL-ACTIVITY

被引:44
|
作者
LOKKER, NA [1 ]
ZENKE, G [1 ]
STRITTMATTER, U [1 ]
FAGG, B [1 ]
MOVVA, NR [1 ]
机构
[1] SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND
来源
EMBO JOURNAL | 1991年 / 10卷 / 08期
关键词
EPITOPE MAPPING; MUTAGENESIS; NEUTRALIZING MONOCLONAL ANTIBODIES; RECEPTOR BINDING SITE; STRUCTURE PREDICTION;
D O I
10.1002/j.1460-2075.1991.tb07746.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A structure - activity relationship study of human interleukin-3 (huIL-3) was performed by functional analysis of huIL-3 deletion and substitution variants combined with epitope mapping of huIL-3 specific neutralizing monoclonal antibodies (mAb). Analysis of the huIL-3 variants was accomplished by defining their capacity to compete with wild-type huIL-3 for binding to the huIL-3 receptor and to induce the proliferation of the huIL-3 dependent cell line M-07. HuIL-3 variants with either 14 amino acids (aa) deleted from the N-terminus or eight aa from the C-terminus retained full biological activity in vitro. An huIL-3 variant, with 18 N-terminal aa deleted, exhibited a > 7-fold reduced receptor binding capacity and proliferative activity. No biological activity could be detected with a variant where 22 C-terminal aa have been deleted. Neutralizing mAb recognizing presumed discontinuous epitopes failed to interact with the latter deletion variant indicating a possible location of their epitopes within the C-terminal region. Computer-aided structure prediction and sequence homology analysis of this region indicated the presence of an amphiphilic alpha-helix with highly conserved residues like Lys110 and Leu111. Substitution of Lys110 with either Glu or Ala resulted in variants with a 10-fold reduced activity in the receptor binding assay and the proliferation assay. Further variants, where Leu111 was substituted by Pro or Met, were totally inactive in these assays. Analysis of the binding of the two neutralizing mAb to these substitution variants showed that they did not bind to either of the Leu111 variants suggesting that Leu111 is part of an active site. Based on our results, a possible model for the structure of the huIL-3 molecule can be constructed with two active sites in close proximity.
引用
收藏
页码:2125 / 2131
页数:7
相关论文
共 50 条
  • [1] ROLE OF LEUCINE RESIDUES IN THE C-TERMINAL REGION OF HUMAN INTERLEUKIN-6 IN THE BIOLOGICAL-ACTIVITY
    NISHIMURA, C
    EKIDA, T
    NOMURA, K
    SAKAMOTO, K
    SUZUKI, H
    YASUKAWA, K
    KISHIMOTO, T
    ARATA, Y
    FEBS LETTERS, 1992, 311 (03) : 271 - 275
  • [2] ROLE OF C-TERMINAL REGION OF MURINE INTERLEUKIN-6 IN BIOLOGICAL-ACTIVITY AND STRUCTURAL CONFORMATION
    WARD, LD
    HAMMACHER, A
    ZHANG, JG
    DISCOLO, J
    TU, GF
    MORITZ, RL
    MORTON, CJ
    NORTON, RS
    SIMPSON, RJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 120 - 120
  • [3] STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF HUMAN INTERLEUKIN-3 - IDENTIFICATION OF RESIDUES REQUIRED FOR BIOLOGICAL-ACTIVITY BY SITE-DIRECTED MUTAGENESIS
    LOKKER, NA
    MOVVA, NR
    STRITTMATTER, U
    FAGG, B
    ZENKE, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (16) : 10624 - 10631
  • [4] ROLE OF DISULFIDE BRIDGES IN DETERMINING THE BIOLOGICAL-ACTIVITY OF INTERLEUKIN-3
    CLARKLEWIS, I
    HOOD, LE
    KENT, SBH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) : 7897 - 7901
  • [5] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF C-TERMINAL FRAGMENTS OF VASOPRESSIN
    GOLUBOVICH, VP
    MARTINOVICH, VP
    USENKO, AB
    SLOBODCHIKOVA, LK
    TITOV, SA
    ASHMARIN, IP
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1988, 22 (06): : 675 - 679
  • [6] BIOLOGICAL-ACTIVITY OF C-TERMINAL PARTIAL SEQUENCES OF SUBSTANCES
    BURY, PRW
    MASHFORD, ML
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1977, 4 (02) : 199 - 199
  • [7] IMPORTANCE OF THE C-TERMINAL ALPHA-HELICAL STRUCTURE FOR GLUCAGONS BIOLOGICAL-ACTIVITY
    KRSTENANSKY, JL
    ZECHEL, C
    TRIVEDI, D
    HRUBY, VJ
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1988, 32 (06): : 468 - 475
  • [8] THE C-TERMINAL REGION OF THE S COMPONENT OF STAPHYLOCOCCAL LEUKOCIDIN IS ESSENTIAL FOR THE BIOLOGICAL-ACTIVITY OF THE TOXIN
    NARIYA, H
    IZAKI, K
    KAMIO, Y
    FEBS LETTERS, 1993, 329 (1-2) : 219 - 222
  • [9] NOVEL C-TERMINAL GASTRIN ANTAGONISTS - SYNTHESIS AND BIOLOGICAL-ACTIVITY
    YASUI, A
    DOUGLAS, AJ
    WALKER, B
    MAGEE, DF
    MURPHY, RF
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1990, 35 (04): : 301 - 305
  • [10] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF C-TERMINAL HEPTAPEPTIDES AND OCTAPEPTIDES OF PANCREOZYMIN
    HARTEL, B
    NIEDRICH, H
    BERGMANN, J
    FAHNDRICH, A
    GORE, E
    PHARMAZIE, 1975, 30 (12): : 814 - 814